Advertisement
Screener

AUDIOCODES LTD. (AUDC) Spending and interest coverage

AUDIOCODES LTD. (AUDC) Spending and interest coverage

  • R&D / revenue · 12 months: Value 21.41%; Formula and calculation Research and development expense / revenue. Period ending 2025-12-31..
  • Stock-based compensation / revenue · 12 months: Value 2.65%; Formula and calculation Share-based compensation / revenue. Period ending 2025-12-31..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2025-12-31; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months21.41%Research and development expense / revenue. Period ending 2025-12-31.

$52.59M ÷ $245.60M × 100 ≈ 21.41%

Stock-based compensation / revenue · 12 months2.65%Share-based compensation / revenue. Period ending 2025-12-31.

$6.51M ÷ $245.60M × 100 ≈ 2.65%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending52.59M USDResearch and Development Expense
Revenue245.60M USD
Stock-based compensation6.51M USDShare-based Payment Arrangement, Noncash Expense
Operating income14.04M USDOperating Income (Loss)
Interest expense · reported / estimated(m)Interest Expense · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2025-12-31$52.59M$245.60M$6.51M$14.04M(m)21.41%2.65%(m)(m)
2024-12-31$52.13M$242.18M$8.23M$17.19M(m)21.52%3.40%(m)(m)
2023-12-31$57.17M$244.38M$11.38M$14.42M$1.56M23.39%4.66%9.22×Reported
2022-12-31$59.84M$275.09M$15.12M$31.32M$325.00K21.75%5.50%96.37×Reported
2021-12-31$53.40M$248.92M$14.16M$39.52M$621.00K21.45%5.69%63.65×Reported
2021-06-30$48.04M$234.64M$11.65M$43.60M(m)20.47%4.96%(m)(m)
2020-12-31$46.07M$220.77M$8.77M$38.35M$657.00K20.87%3.97%58.37×Reported
2020-06-30$44.35M$209.75M$6.79M$-4.95M(m)21.14%3.24%(m)(m)
2019-12-31$41.20M$200.29M$5.29M$-9.55M$198.00K20.57%2.64%-48.25×Reported
2019-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2018-12-31$34.66M$176.22M$3.29M$16.36M$266.00K19.67%1.87%61.50×Reported
2017-12-31$30.35M$156.74M$2.31M$9.65M$294.00K19.36%1.47%32.82×Reported
2016-12-31$29.14M$145.57M$2.41M$7.75M$262.00K20.02%1.66%29.60×Reported
2015-12-31$28.00M$139.76M$2.37M$2.71M$278.00K20.03%1.70%9.73×Reported
2015-06-30$30.72M$147.95M$2.54M$2.25M(m)20.77%1.71%(m)(m)
2014-12-31$32.27M$151.58M$2.55M$3.50M$415.00K21.29%1.68%8.44×Reported
2014-06-30$30.14M$144.79M$2.30M$2.47M(m)20.82%1.59%(m)(m)
2013-12-31$28.19M$137.23M$1.70M$2.74M$617.00K20.54%1.24%4.44×Reported
2013-09-30$27.23M$133.79M$1.51M$2.50M(m)20.35%1.13%(m)(m)
2013-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2012-12-31$28.68M$127.49M$1.53M$-3.73M$900.00K22.49%1.20%-4.15×Reported
2012-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2011-12-31$32.15M$155.83M$2.32M$7.26M(m)20.63%1.49%(m)(m)
2010-12-31$30.19M$150.04M$1.37M$10.44M(m)20.12%0.91%(m)(m)
2009-12-31$29.95M$125.89M$1.99M$-184.00K(m)23.79%1.58%(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.